Agency approves the first overdose reversal drug to be available without a prescription
The Food and Drug Administration (FDA) approved the opioid reversal drug Narcan for over-the-counter sales, making it the first naloxone-based drug to be available without a prescription. Emergent BioSolution, the producers of Narcan, said that it expects the life-saving nasal spray to be available for purchase by late summer. Opioid addiction experts say that this will be a crucial tool in the fight against opioid overdoses, but still are concerned about drug companies’ price-hiking tendencies.
“I think it’s a big win. The question now remains about the cost,” said Noa Krawczyk, assistant professor at the NYU Grossman School of Medicine. “For people who need it most, it needs to be at a lower price point than what it is currently available,” said Maryann Mason, associate professor of emergency medicine at Northwestern University.
As the Lord Leads, Pray with Us…
- That the FDA’s approval of this drug helps America’s fight against opioid deaths.
- For American scientific leaders as they thoroughly review conducted studies to make sound decisions.
- That the administration officials continue to seek to offer as much support as possible to those suffering with addiction.
Sources: Department of Energy,
